
Texas Children’s Global Health Stories
Texas Children’s CORBEVAX COVID-19 Vaccine receives Emergency Use Authorization
Texas Children’s and Baylor College of Medicine announced on December 28, that CORBEVAX, a protein sub-unit COVID-19 Vaccine, whose technology was created and engineered at its Center for Vaccine Development (CVD), has received Emergency Use Authorization (EUA) approval from the Drugs Controller General of India (DCGI) to launch first in India, with other underserved countries to follow.
Johnson & Johnson’s COVID-19 vaccine: Answering the big questions
As a vaccine developer and researcher, I’m incredibly encouraged by the progress made thus far as we continue in our fight against COVID-19. Following the recent news regarding this third vaccine, I wanted to share some of the most common questions about Johnson & Johnson’s vaccine.
There's a frantic global race for a COVID vaccine, and Houston hopes to be an ultimate winner
Peter Hotez and Maria Bottazzi, co-directors of Texas Children's Hospitals Center for Vaccine Development, talk about developing vaccine for COVID-19 Thursday, June 18, 2020, in Houston. The lab has been working to develop vaccine for COVID-19 with yeast.
Dr. Bip Nandi, pediatric surgeon for Texas Children’s Global Surgery Program in Malawi, shares about the pediatric surgical services offered in Central and Northern Malawi.